Infuse

Medtronic Inc. said Wednesday that it is giving Yale University a $2.5 million grant to conduct an ambitious, independent review of the safety and effectiveness of its controversial spine treatment called Infuse Bone Graft.

Medtronic Funds Yale Safety Study Ron Winslow 2011

Another raised questions about the safety and effectiveness of one of the company's spinal devices, called Infuse.

Medtronic Profit Falls on Weaker Margins Anjali Athavaley 2011

RhBMP-2 is used in another Medtronic spine device known as Infuse that is currently on the market.

FDA Rejects Medtronic Spine Device Steven Russolillo 2011

The product, called Infuse Bone Graft, has already been the subject of a series of inquiries by the Senate committee, as well as of an ongoing investigation by the Justice Department into its use beyond its official Food and Drug Administration indication.

Medtronic Surgeons Held Back, Study Says John Carreyrou 2011

The product, called Infuse Bone Graft, has already been the subject of a series of inquiries by the Senate committee, as well as of an ongoing investigation by the Justice Department into its use beyond its official Food and Drug Administration indication.

Medtronic Surgeons Held Back, Study Says John Carreyrou 2011

In particular, a bone-growth product called Infuse has been hurt by a Food and Drug Administration safety notice in July over serious complications when Infuse is used in vertebrae in the neck.

Recalls Hurt Medtronic Earnings 2009

Dr. Kuklo, a former Army surgeon, did the study of a Medtronic Inc. bone-growth product called Infuse that Army officials said was based on falsified information.

Surgeon Resigns From Washington University 2009

Medtronic, whose bone-growth protein called Infuse was the focus of the Kuklo study, has said it paid him nearly $800,000 over the past three years as a consultant.

Medtronic Gets Subpoena on Surgeon's Product Study 2009

What Dr. Polly didn't disclose during his testimony was that his trip to Washington was paid for by Medtronic Inc., the big medical-device maker whose bone growth product, called Infuse, has been used to treat soldiers, according to company records.

Spine Surgeon Didn't Disclose Medtronic Pay in Testimony 2009

Dr. Kuklo's research, published in August and since retracted by the Journal of Bone and Joint Surgery, seemingly showed advantages in healing of leg injuries when doctors used the bone protein, called Infuse, from Medtronic Inc.Dr. Kuklo is a consultant for the Minneapolis company; Medtronic said he didn't have any company affiliation at the time he worked on the study.

Army Investigation Cites Problems in Surgeon's Study 2009